microdosing glp-1 for menopause Let's talk about medications in the context of perimenopause and menopause, because this is where the conversation most often gets flattened into something it is not. This is not about vanity GLP-1 Agonists in Perimenopause: Unique

We currently help patients receive naltrexone prescriptions so that they can take control of their drinking whether that entails simply reducing consumption or binge drinking, or if it means abstaining from alcohol long-term

Do you have to stop drinking before starting naltrexone

The transient nature of semaglutide's side effects, combined with their predictable onset during dose escalation, allows for better patient preparation and management

You won't start on a high, 'target' dose

Many patients receive B12 support to help with overall energy as their eating patterns shift during the program

These experiences are anecdotal and not standardized